Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00723008 · ClinicalTrials.gov registry record · Phase 2

Cranial Electrotherapy Stimulation in Burned Patients

A Phase 2 study of Burns and Post-Traumatic Stress Disorders, sponsored by United States Army Institute of Surgical Research.

Completed
Registry status
Phase 2
Development phase
20
Enrollment target
1
Study location

NCT00723008 is a Phase 2 study of Burns and Post-Traumatic Stress Disorders that has completed, run by United States Army Institute of Surgical Research. The registered enrollment target is 20 participants, below the 83-participant average among 36 other Burns trials with a reported enrollment target (76% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00723008, a Phase 2 study of Burns and Post-Traumatic Stress Disorders, has completed, sponsored by United States Army Institute of Surgical Research.

COMPLETED
Registry status
Phase 2
Development phase
20 participants
Enrollment target
1
Study location

Study Summary

To find out if Cranial Electrotherapy Stimulation is a useful treatment for people who have been burned and have Post Traumatic Stress Disorder. CES may be helpful in giving relief to some or all of those symptoms.

Interventions

  • DEVICE Alpha Stim 100 (Cranial Electrotherapy Stimulation)

Study Locations (1)

Texas

  • USAISR - Fort Sam Houston

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2007-05
Est. Completion 2010-12
Phase Phase 2

What the Registry Record Tells You About NCT00723008

The ClinicalTrials.gov registry entry for NCT00723008 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 83-participant average among 36 other Burns trials with a reported enrollment target (76% lower). The listed sponsor is United States Army Institute of Surgical Research, which has 17 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Burns appearing as the primary indexed condition, and to 1 intervention - of which Alpha Stim 100 (Cranial Electrotherapy Stimulation) is the first listed.

NCT00723008 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT00723008 about?

NCT00723008 is a clinical study titled "Cranial Electrotherapy Stimulation in Burned Patients". To find out if Cranial Electrotherapy Stimulation is a useful treatment for people who have been burned and have Post Traumatic Stress Disorder. CES may be helpful in giving relief to some or all of those symptoms.

What is the current status of trial NCT00723008?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 20 participants. The study started on 2007-05. Estimated completion is 2010-12.

What conditions does trial NCT00723008 study?

This clinical trial studies the following conditions: Burns, Post-Traumatic Stress Disorders.

What interventions are being tested in trial NCT00723008?

The interventions under investigation include: Alpha Stim 100 (Cranial Electrotherapy Stimulation) (DEVICE).

Who is sponsoring clinical trial NCT00723008?

This trial is sponsored by United States Army Institute of Surgical Research, which has 17 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00723008 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Burns

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.